Risk of nonmelanoma skin cancer in Italian organ transplant recipients: a registry-based study.

被引:106
作者
Naldi, L
Fortina, AB
Lovati, S
Barba, A
Gotti, E
Tessari, G
Schena, D
Diociaiuti, A
Nanni, G
La Parola, IL
Masini, C
Piaserico, S
Peserico, A
Cainelli, T
Remuzzi, G
机构
[1] Ospedali Riuniti, Clin Dermatol, Bergamo, Italy
[2] Ospedali Riuniti, Dept Dermatol, I-24100 Bergamo, Italy
[3] Ospedali Riuniti, Dept Nephrol, Bergamo, Italy
[4] Univ Padua, Dept Dermatol, I-35100 Padua, Italy
[5] Univ Verona, Dept Dermatol, I-37100 Verona, Italy
[6] Univ Cattolica, Dept Dermatol, Rome, Italy
[7] Univ Cattolica, Dept Surg, Rome, Italy
[8] Inst S Maria & S Gallicano, Dept Dermatol, Rome, Italy
关键词
D O I
10.1097/00007890-200011270-00015
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Organ transplant recipients are at an increased risk of nonmelanoma skin cancer. Few data concern heart transplantation and populations from southern Europe. Methods. A total of 1329 patients who received their first kidney (1062 subjects) or heart allograft (267 subjects) were included in a partly retrospective cohort study to evaluate the risk of skin cancer. The incidence rate per 1000 person-years and the cumulative incidence were computed. Standardized morbidity ratio was estimated by comparison with Italian cancer registry data. To analyze the role of potential prognostic factors, Cox's regression method was used. Results. The overall incidence rate of nonmelanoma skin cancer was 10.0 cases per 1000 posttransplant person-years (95% confidence interval 8.2-11.7). This estimate was far higher than expected in the general population. The overall risk of developing skin cancer increased from a cumulative incidence of 5.8% after 5 posttransplant years to an incidence of 10.8% after 10 years of graft survival. In a Cox proportional hazard risk model, the most important factors that appeared to favor the development of skin cancer were age to transplantation and sex. After adjustment for age at transplantation and sex, no definite increased risk was documented among heart as compared with kidney transplant recipients. Conclusions. Our study confirms the increased risk of nonmelanoma skin cancer among organ transplant recipients in a southern European population.
引用
收藏
页码:1479 / 1484
页数:6
相关论文
共 40 条
[2]  
BARR BBB, 1989, LANCET, V1, P124
[3]   The risk of skin cancer in renal transplant recipients in Queensland, Australia [J].
Bavinck, JNB ;
Hardie, DR ;
Green, A ;
Cutmore, S ;
MacNaught, A ;
OSullivan, B ;
Siskind, V ;
VanDerWoude, FJ ;
Hardie, IR .
TRANSPLANTATION, 1996, 61 (05) :715-721
[4]  
BLOHME I, 1992, TRANSPLANT P, V24, P313
[5]  
BOUWASBAVINCK JN, 1994, J NEPHROL, V7, P261
[6]  
BOYLE J, 1984, LANCET, V1, P702
[7]   THE PREVALENCE OF SKIN DISORDERS IN RENAL-ALLOGRAFT RECIPIENTS RECEIVING CYCLOSPORINE-A COMPARED WITH THOSE RECEIVING AZATHIOPRINE [J].
BUNNEY, MH ;
BENTON, EC ;
BARR, BB ;
SMITH, IW ;
ANDERTON, JL ;
HUNTER, JAA .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1990, 5 (05) :379-382
[8]  
COUETIL JP, 1990, J HEART TRANSPLANT, V9, P622
[9]   Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens [J].
Dantal, J ;
Hourmant, M ;
Cantarovich, D ;
Giral, M ;
Blancho, G ;
Dreno, B ;
Soulillou, JP .
LANCET, 1998, 351 (9103) :623-628
[10]   SKIN-CANCER IN HEART-TRANSPLANT RECIPIENTS [J].
ESPANA, A ;
REDONDO, P ;
FERNANDEZ, AL ;
ZABALA, M ;
HERREROS, J ;
LLORENS, R ;
QUINTANILLA, E .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1995, 32 (03) :458-465